Fundraising Fox

Steve Holtzman

Investor

Advisor at Amplify Partners

Center Harbor, New Hampshire, United States

About

A biotech platform strategist and dealmaker, Holtzman founded DNX Corporation, served as Chief Business Officer at Millennium Pharmaceuticals, led Infinity Pharmaceuticals as CEO, was EVP of Corporate Development at Biogen, and was founding CEO of Decibel Therapeutics (acquired by Regeneron in 2023). He now advises biotech founders and holds executive chair and board roles at several biotech companies.

Experience

  1. Berklee College of MusicTrusteecurrent2014 β€” presentBoston, MA
  2. Decibel TherapeuticsPresident and Chief Executive Officer2016 β€” 2020Cambridge, MA
  3. Biogen IdecExecutive Vice President, Corporate Development2011 β€” 2016Cambridge, MA
  4. Infinity PharmaceuticalsFounder and Chair, Board of Directors2001 β€” 2012Cambridge, MA
  5. Infinity PharmaceuticalsPresident and CEO, Founder2001 β€” 2010Cambridge, MA
  6. Berklee College of MusicTrustee2003 β€” 2012Boston, MA
  7. The Hastings CenterVice Chairman, Board of Trustees1999 β€” 2010Garrison, NY
  8. Millennium PharmaceuticalsChief Business Officer1994 β€” 2001Cambridge, MA
  9. US National Bioethics CommissionPresidential Appointee1996 β€” 2001Washington, D.C.
  10. DNX CorporationFounder and Executive Vice President; President DNX Biotherapeutics1986 β€” 1994Princeton, NJ

Education

  1. University of OxfordB.Phil., Philosophy1976 β€” 1979
  2. Michigan State UniversityBA, Philosophy1972 β€” 1976

Same school

Shared employers

Colleagues at Amplify Partners